TrialLancet (London, England)2020

Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies.

Reuben Benjamin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.